OR WAIT null SECS
© 2022 MJH Life Sciences and Consultant Live. All rights reserved.
May 07, 2021
James Januzzi, MD, and Javed Butler, MD, MPH, MBA, discuss emerging agents, vericiguat and intravenous (IV) iron, in the treatment landscape for heart failure with reduced ejection fraction and advice for community physicians managing patients with heart failure.
April 30, 2021
Cardiology experts discuss challenges in achieving the optimal therapy for patients with heart failure and the influence of patient lifestyle and medical factors.
Insights on approaching the initiation of SGLT2 inhibitors for the treatment of heart failure with reduced ejection fraction.
April 23, 2021
Javed Butler, MD, MPH, MBA, reviews the historical background of using SGLT2 inhibitors and the impact on patients with heart failure with reduced ejection fraction.